---
title: The Hard Thing about Medtech Startups & Are they Worth it?
summary: "Medtech startups face unique challenges, including lengthy FDA/CE approval processes, complex clinical trials, and long sales cycles, making them difficult to fund and sustain. However, mission-driven founders can overcome these obstacles by securing alternative funding and leveraging regulatory advantages. Despite the hurdles, the societal impact and potential healthcare improvements make the effort worthwhile."
---



- [MedTech Entrepreneur](https://medium.com/@fouadalnoor1/the-hard-thing-about-medtech-startups-why-theyre-worth-it-de41d4198084)



- [Harvard Business Review](https://hbr.org/2006/05/why-innovation-in-health-care-is-so-hard)
